Insiders / Cutler Adam D.
Cutler Adam D.
CIK 1722673personinsider
Companies
4
First seen
Jan 14, 2021
Last activity
Dec 5, 2025
Companies
| Company | Shares held | Latest |
|---|---|---|
| Navidea Biopharmaceuticals, Inc. · NAVB | 10,000 | — |
| Mural Oncology plc · MURA | 0 | — |
| InMed Pharmaceuticals Inc. · INM | — | — |
| Threshold Pharmaceuticals Inc · MTEM | — | — |
All securities held
4 positions · latest reported per filing
Shares
| Company | Security | Shares |
|---|---|---|
| Navidea Biopharmaceuticals, Inc. | Common stock | 10,000 |
Derivatives
| Company | Security | Shares |
|---|---|---|
| InMed Pharmaceuticals Inc. | Options | 16,122 |
| Navidea Biopharmaceuticals, Inc. | Options | 2,500 |
| Threshold Pharmaceuticals Inc | Options | 125,000 |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Oct 31, 2024 | Sell Open-market sale | MURA Mural Oncology plc Ordinary Shares | $25.3K | -7K -9.41% | 71,438 | low |
| Nov 3, 2025 | Sell Open-market sale | MURA Mural Oncology plc Ordinary Shares | $14.9K | -7K -6.72% | 99,290 | low |
| Jan 13, 2021 | Grant Grant or award | NAVB Navidea Biopharmaceuticals, Inc. Common Stock | $3 |